Ashkan Vaziri

Biosensics, LLC

NIH Rank #1803
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$3.7M
Fiscal year 2024
Grants Awarded
7
Active NIH grants
National Rank
#1,803
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $3.7M across 7 grants · National rank #1803.

Top grants by award amount

Ashkan Vaziri's NIH grant portfolio, ranked by award amount.

  • 5R44AG084327-02R44
    Software Platform for Automatic, Opportunistic Screening of Vertebral Compression Fractures
    $986K
    award amount
  • 5R44HD084035-06R44
    StrokeWear: A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Home Daily Life.
    $932.9K
    award amount
  • 5R44AG081031-02R44
    Automatic, Opportunistic Surveillance of Hip Bone Fragility in X-ray Images
    $918.8K
    award amount
  • 1U44DA061027-01U44
    ODAlert: Wearable Device for Automatic Detection of Opioid-Induced Respiratory Arrest
    $400K
    award amount
  • 75N91024C00094-0-9999-1N43
    FY24 SBIR PHASE I TOPIC NO. 459 PROJECT TITLE: AN AUTOMATED SCREENING PLATFORM FOR EARLY IDENTIFICATION OF MALNUTRITION IN CANCER PATIENTS
    $400K
    award amount
  • 3R44AG081031-02S1R44
    Automatic, Opportunistic Surveillance of Hip Bone Fragility in X-ray Images
    $50K
    award amount
  • 3R44AG080861-02S1R44
    A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration Syndromes
    $50K
    award amount

Affiliation

Institutions that have administered grants for Ashkan Vaziri.

Affiliated with Biosensics, LLC (MA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Biosensics, LLC
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1803
  6. 2024
    Entered Top 25% Nationally
    Ranked #1803
  7. 2024
    Entered Top 10% Nationally
    Ranked #1803